- Home
- CAPR vs PTNM Comparison
CAPR vs PTNM Comparison
Compare CAPR & PTNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAPR
- PTNM
- Stock Information
- Founded
- CAPR 2005
- PTNM 2013
- Country
- CAPR United States
- PTNM Hong Kong
- Employees
- CAPR N/A
- PTNM N/A
- Industry
- CAPR Biotechnology: Biological Products (No Diagnostic Substances)
- PTNM
- Sector
- CAPR Health Care
- PTNM
- Exchange
- CAPR Nasdaq
- PTNM Nasdaq
- Market Cap
- CAPR 324.6M
- PTNM 320.2M
- IPO Year
- CAPR N/A
- PTNM 2025
- Fundamental
- Price
- CAPR $6.28
- PTNM $1.85
- Analyst Decision
- CAPR Strong Buy
- PTNM
- Analyst Count
- CAPR 8
- PTNM 0
- Target Price
- CAPR $24.75
- PTNM N/A
- AVG Volume (30 Days)
- CAPR 1.4M
- PTNM 3.3M
- Earning Date
- CAPR 08-11-2025
- PTNM 01-01-0001
- Dividend Yield
- CAPR N/A
- PTNM N/A
- EPS Growth
- CAPR N/A
- PTNM N/A
- EPS
- CAPR N/A
- PTNM 0.05
- Revenue
- CAPR $13,392,150.00
- PTNM $9,644,233.00
- Revenue This Year
- CAPR N/A
- PTNM N/A
- Revenue Next Year
- CAPR $6,061.53
- PTNM N/A
- P/E Ratio
- CAPR N/A
- PTNM $32.65
- Revenue Growth
- CAPR N/A
- PTNM 9.87
- 52 Week Low
- CAPR $3.98
- PTNM $0.98
- 52 Week High
- CAPR $23.40
- PTNM $14.79
- Technical
- Relative Strength Index (RSI)
- CAPR 36.33
- PTNM N/A
- Support Level
- CAPR $6.17
- PTNM N/A
- Resistance Level
- CAPR $7.30
- PTNM N/A
- Average True Range (ATR)
- CAPR 0.43
- PTNM 0.00
- MACD
- CAPR -0.11
- PTNM 0.00
- Stochastic Oscillator
- CAPR 4.53
- PTNM 0.00
About CAPR Capricor Therapeutics Inc.
Capricor Therapeutics Inc is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with high unmet medical needs. The company's product pipeline includes CAP-1002, deramiocel an allogeneic cardiac-derived cell therapy. Deramiocel is currently advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy. Through its proprietary StealthXTM platform, the group uses its exosome technology to conduct preclinical research focused on vaccinology, delivering oligonucleotides, proteins, and small molecules to treat.
About PTNM Pitanium Limited Class A Ordinary shares
Pitanium Ltd is a retailer in Hong Kong focusing on the sale of its proprietary brand of skincare and personal care products, especially haircare products, namely PITANIUM and BIG PI online and offline with six retail stores situated in Prime shopping destinations in Hong Kong. The company emphasizes product design and development with an in-house product development team working closely with its original equipment manufacturing (OEM) and original design manufacturing (ODM) suppliers.